Honasa Consumer Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 21, 2025, 8:58 am

Quick Insight

Honasa Consumer Ltd, operating in the personal care industry, currently shows a P/E ratio of 123, indicating a relatively high valuation compared to its earnings. With a ROE of 5.93% and ROCE of 7.50%, the company's profitability and capital efficiency seem moderate. The low OPM of 4% raises concerns about operational efficiency. However, the company's strong balance sheet with reserves of ₹875 Cr and a comfortable interest coverage ratio of 11.64x provide some stability. The high P/BV of 6.40x suggests the stock may be overvalued based on its book value. Overall, investors should carefully assess the company's growth prospects and operational improvements before considering an investment in Honasa Consumer Ltd.

Competitors of Honasa Consumer Ltd

All Competitor Stocks of Honasa Consumer Ltd

Quarterly Result

Last Updated: August 19, 2025, 1:40 pm

Below is a detailed analysis of the quarterly data for Honasa Consumer Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 584.00 Cr.. The value appears strong and on an upward trend. It has increased from 523.00 Cr. (Mar 2025) to 584.00 Cr., marking an increase of 61.00 Cr..
• For Expenses, as of Jun 2025, the value is 542.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 499.00 Cr. (Mar 2025) to 542.00 Cr., marking an increase of 43.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 42.00 Cr.. The value appears strong and on an upward trend. It has increased from 24.00 Cr. (Mar 2025) to 42.00 Cr., marking an increase of 18.00 Cr..
• For OPM %, as of Jun 2025, the value is 7.00%. The value appears strong and on an upward trend. It has increased from 5.00% (Mar 2025) to 7.00%, marking an increase of 2.00%.
• For Other Income, as of Jun 2025, the value is 23.00 Cr.. The value appears strong and on an upward trend. It has increased from 20.00 Cr. (Mar 2025) to 23.00 Cr., marking an increase of 3.00 Cr..
• For Interest, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
• For Depreciation, as of Jun 2025, the value is 8.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 10.00 Cr. (Mar 2025) to 8.00 Cr., marking a decrease of 2.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 54.00 Cr.. The value appears strong and on an upward trend. It has increased from 32.00 Cr. (Mar 2025) to 54.00 Cr., marking an increase of 22.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 23.00% (Mar 2025) to 26.00%, marking an increase of 3.00%.
• For Net Profit, as of Jun 2025, the value is 40.00 Cr.. The value appears strong and on an upward trend. It has increased from 25.00 Cr. (Mar 2025) to 40.00 Cr., marking an increase of 15.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.23. The value appears strong and on an upward trend. It has increased from 0.76 (Mar 2025) to 1.23, marking an increase of 0.47.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 15, 2025, 3:11 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:05 pm

Below is a detailed analysis of the balance sheet data for Honasa Consumer Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 325.00 Cr.. The value appears strong and on an upward trend. It has increased from 324.00 Cr. (Mar 2024) to 325.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 875.00 Cr.. The value appears strong and on an upward trend. It has increased from 800.00 Cr. (Mar 2024) to 875.00 Cr., marking an increase of 75.00 Cr..
• For Borrowings, as of Mar 2025, the value is 110.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 110.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 434.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 387.00 Cr. (Mar 2024) to 434.00 Cr., marking an increase of 47.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,744.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,622.00 Cr. (Mar 2024) to 1,744.00 Cr., marking an increase of 122.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 334.00 Cr.. The value appears strong and on an upward trend. It has increased from 170.00 Cr. (Mar 2024) to 334.00 Cr., marking an increase of 164.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 290.00 Cr.. The value appears to be declining and may need further review. It has decreased from 426.00 Cr. (Mar 2024) to 290.00 Cr., marking a decrease of 136.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,120.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,026.00 Cr. (Mar 2024) to 1,120.00 Cr., marking an increase of 94.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,744.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,622.00 Cr. (Mar 2024) to 1,744.00 Cr., marking an increase of 122.00 Cr..

Notably, the Reserves (875.00 Cr.) exceed the Borrowings (110.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Honasa Consumer Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 2.24. This value is below the healthy minimum of 5. It has decreased from 3.57 (Mar 24) to 2.24, marking a decrease of 1.33.
• For Diluted EPS (Rs.), as of Mar 25, the value is 2.23. This value is below the healthy minimum of 5. It has decreased from 3.55 (Mar 24) to 2.23, marking a decrease of 1.32.
• For Cash EPS (Rs.), as of Mar 25, the value is 3.62. This value is within the healthy range. It has decreased from 4.35 (Mar 24) to 3.62, marking a decrease of 0.73.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 36.28. It has increased from -21.52 (Mar 24) to 36.28, marking an increase of 57.80.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 36.28. It has increased from -21.52 (Mar 24) to 36.28, marking an increase of 57.80.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 63.56. It has increased from 59.21 (Mar 24) to 63.56, marking an increase of 4.35.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 4.53. This value is within the healthy range. It has decreased from 5.76 (Mar 24) to 4.53, marking a decrease of 1.23.
• For PBIT / Share (Rs.), as of Mar 25, the value is 3.14. This value is within the healthy range. It has decreased from 4.82 (Mar 24) to 3.14, marking a decrease of 1.68.
• For PBT / Share (Rs.), as of Mar 25, the value is 2.75. This value is within the healthy range. It has decreased from 4.54 (Mar 24) to 2.75, marking a decrease of 1.79.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 2.23. This value is within the healthy range. It has decreased from 3.41 (Mar 24) to 2.23, marking a decrease of 1.18.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 2.23. This value is within the healthy range. It has decreased from 3.45 (Mar 24) to 2.23, marking a decrease of 1.22.
• For PBDIT Margin (%), as of Mar 25, the value is 7.12. This value is below the healthy minimum of 10. It has decreased from 9.72 (Mar 24) to 7.12, marking a decrease of 2.60.
• For PBIT Margin (%), as of Mar 25, the value is 4.94. This value is below the healthy minimum of 10. It has decreased from 8.13 (Mar 24) to 4.94, marking a decrease of 3.19.
• For PBT Margin (%), as of Mar 25, the value is 4.33. This value is below the healthy minimum of 10. It has decreased from 7.66 (Mar 24) to 4.33, marking a decrease of 3.33.
• For Net Profit Margin (%), as of Mar 25, the value is 3.51. This value is below the healthy minimum of 5. It has decreased from 5.75 (Mar 24) to 3.51, marking a decrease of 2.24.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.51. This value is below the healthy minimum of 8. It has decreased from 5.82 (Mar 24) to 3.51, marking a decrease of 2.31.
• For Return on Networth / Equity (%), as of Mar 25, the value is 6.16. This value is below the healthy minimum of 15. It has increased from -16.02 (Mar 24) to 6.16, marking an increase of 22.18.
• For Return on Capital Employeed (%), as of Mar 25, the value is 7.86. This value is below the healthy minimum of 10. It has decreased from 12.82 (Mar 24) to 7.86, marking a decrease of 4.96.
• For Return On Assets (%), as of Mar 25, the value is 4.06. This value is below the healthy minimum of 5. It has decreased from 6.84 (Mar 24) to 4.06, marking a decrease of 2.78.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.21. It has decreased from 1.48 (Mar 24) to 1.21, marking a decrease of 0.27.
• For Current Ratio (X), as of Mar 25, the value is 2.07. This value is within the healthy range. It has decreased from 2.73 (Mar 24) to 2.07, marking a decrease of 0.66.
• For Quick Ratio (X), as of Mar 25, the value is 1.74. This value is within the healthy range. It has decreased from 2.43 (Mar 24) to 1.74, marking a decrease of 0.69.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 11.64. This value is within the healthy range. It has decreased from 20.66 (Mar 24) to 11.64, marking a decrease of 9.02.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 6.75. This value is within the healthy range. It has decreased from 13.23 (Mar 24) to 6.75, marking a decrease of 6.48.
• For Enterprise Value (Cr.), as of Mar 25, the value is 7,216.23. It has decreased from 12,548.96 (Mar 24) to 7,216.23, marking a decrease of 5,332.73.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.49. This value exceeds the healthy maximum of 3. It has decreased from 6.54 (Mar 24) to 3.49, marking a decrease of 3.05.
• For EV / EBITDA (X), as of Mar 25, the value is 49.00. This value exceeds the healthy maximum of 15. It has decreased from 67.18 (Mar 24) to 49.00, marking a decrease of 18.18.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.65. This value exceeds the healthy maximum of 3. It has decreased from 6.79 (Mar 24) to 3.65, marking a decrease of 3.14.
• For Price / BV (X), as of Mar 25, the value is 6.40. This value exceeds the healthy maximum of 3. It has increased from -18.68 (Mar 24) to 6.40, marking an increase of 25.08.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.65. This value exceeds the healthy maximum of 3. It has decreased from 6.79 (Mar 24) to 3.65, marking a decrease of 3.14.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness